Achieve Life Sciences (ACHV) Stock Price, Quote, News & History | Benzinga

Achieve Life Sciences Inc (ACHV) Stock Price, Quote, News & History

ACHVNASDAQ

Trade with Public

Trade with Public

$7.99

-0.03-0.37%

At close: Aug 20, 5:00 PM EST

$8.08

0.060.75%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$7.99

Volume / Avg.

43.00 / 1.81M

Day Range

- - -

52 Wk Range

2.60 - 8.61

Market Cap

$831.45M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

15.9%

Days to Cover

15.04

Recent Achieve Life Sciences, Inc. News

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See what analysts think of MTN stock.

Avi Kapoor

Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.

Avi Kapoor

FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned

FDA rejects Achieve Life Sciences application for cytisinicline tied to manufacturing issues, with NDA resubmission planned in Q4 2026.

Vandana Singh

SPCX, INTC, NFLX And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

Retail investors talked up five hot stocks this week (June 15 to June 18) on X and Reddit's r/WallStreetBets: SPCX, MSFT, NFLX, INTC, ACHV.

Rishabh Mishra

Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

Achieve Life Sciences taps Adare for cytisinicline manufacturing as stock falls; reports wider losses and shifts US launch timeline to 2027.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-47.02M

Investing Cash Flow (TTM)

-135.47M

Financing Cash Flow (TTM)

178.78M

Free Cash Flow (TTM)

-47.21M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-3.71M

Analyst Trends and Forecast

1

Mar

2

Apr

1

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$649.84M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-20.78%

Earnings Yield % (FWD)

-18.96%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.14

Company Debt

Total Debt

$14.91M

LT Debt

$7.46M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$47.96M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$7.99

Volume / Avg.

43.00 / 1.81M

Day Range

- - -

52 Wk Range

2.60 - 8.61

Market Cap

$831.45M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

15.9%

Days to Cover

15.04

About

Sector

Health Care

Industry

Biotechnology

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Achieve Life Sciences (ACHV) stock?

A

You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Achieve Life Sciences (ACHV) competitors?

A

Other companies in Achieve Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Achieve Life Sciences (ACHV) stock?

A

Achieve Life Sciences has a consensus price target of $14.56.

Q

What is the current price for Achieve Life Sciences (ACHV)?

A

The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $8.08 last updated August 21, 2026 at 6:35 PM EDT.

Q

Does Achieve Life Sciences (ACHV) pay a dividend?

A

There are no upcoming dividends for Achieve Life Sciences.

Q

When is Achieve Life Sciences (NASDAQ:ACHV) reporting earnings?

A

Achieve Life Sciences does not have any upcoming earnings scheduled.

Q

Is Achieve Life Sciences (ACHV) going to split?

A

There is no upcoming split for Achieve Life Sciences.

Q

What sector and industry does Achieve Life Sciences (ACHV) operate in?

A

Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.